TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18091183

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with mitomycin C (T+MMC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ahmed glaucoma implant with mitomycin C (AGI+MMC)
Number of subjects: 30
Study: 15072248

Group type: EXPERIMENTAL
Intervention: Leukocyte-depletion group (n = 13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (n = 13)
Number of subjects: 26
Study: 11642577

Group type: EXPERIMENTAL
Intervention: Constant dosage intranasal immunotherapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 20673423

Group type: EXPERIMENTAL
Intervention: Intradiscal oxygen-ozone injection
Number of subjects: 93
Study: 8044941

Group type: EXPERIMENTAL
Intervention: ranolazine 30 mg tid
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: ranolazine 60 mg tid
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: ranolazine 120 mg tid
Number of subjects: 318

Group type: COMPARATOR
Intervention: placebo tid
Number of subjects: 318
Study: 3378659

Group type: EXPERIMENTAL
Intervention: Netilmicin administered intravenously or intramuscularly every 12 h at a dosage of 2.0-4.4 mg/kg (mean 3.5 mg/kg) for 5-15 days (mean 11 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Netilmicin administered intravenously or intramuscularly
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Netilmicin therapy
Number of subjects: 34
Study: 31233629

Group type: EXPERIMENTAL
Intervention: 5% fluorocalcium phosphosilicate toothpaste (Group A)
Number of subjects: 75

Group type: COMPARATOR
Intervention: 8% arginine and calcium carbonate toothpaste (Group B)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo toothpaste (Group C)
Number of subjects: 75
Study: 28377394

Group type: EXPERIMENTAL
Intervention: Suanzaoren decoction (SZRD) granule plus zolpidem tartrate (ZT) placebo
Number of subjects: 150

Group type: COMPARATOR
Intervention: Zolpidem tartrate (ZT) tablet plus SZRD granule placebo
Number of subjects: 150

Group type: COMPARATOR
Intervention: Zolpidem tartrate (ZT) placebo and SZRD granule placebo
Number of subjects: 150
Study: 26129925

Group type: EXPERIMENTAL
Intervention: Somatostatin analogues
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 23831492

Group type: EXPERIMENTAL
Intervention: LHE-delivered 12-session translation of the Diabetes Prevention Program (DPP)
Number of subjects: 116
Study: 21569471

Group type: EXPERIMENTAL
Intervention: Specialist Medical and Mental Health Unit
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 300
Study: 19298568

Group type: EXPERIMENTAL
Intervention: Electroanatomically guided ablation (Carto)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Conventional ablation
Number of subjects: 210
Study: 16821349

Group type: EXPERIMENTAL
Intervention: SpeediCath Set
Number of subjects: 29

Group type: COMPARATOR
Intervention: Actreen Set
Number of subjects: 29
Study: 15266206

Group type: EXPERIMENTAL
Intervention: APOE disclosure in a risk assessment protocol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: APOE odds ratios
Number of subjects: 0
Study: 10667721

Group type: EXPERIMENTAL
Intervention: Polyflux membrane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresenius Polysulfone membrane
Number of subjects: 0
Study: 9345682

Group type: EXPERIMENTAL
Intervention: Manipulation of the cervical spine on the side of an enlarged cortical map
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Manipulation of the cervical spine on the side opposite an enlarged cortical map
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Manipulation of the cervical spine
Number of subjects: 500
Study: 12085760

Group type: EXPERIMENTAL
Intervention: Immediate overdentures on 2 lower canines
Number of subjects: 74

Group type: COMPARATOR
Intervention: Immediate complete dentures
Number of subjects: 74
Study: 3296635

Group type: EXPERIMENTAL
Intervention: somatrem, 0.5 IU/kg body weight/week for 3‐14 months
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: somatrem
Number of subjects: 62
Study: 29886507

Group type: EXPERIMENTAL
Intervention: Ground kayak paddling (GKP) exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 27626492

Group type: EXPERIMENTAL
Intervention: High expression of PROX1 protein in IDH-mutant anaplastic astrocytomas and secondary glioblastomas
Number of subjects: 340

Group type: COMPARATOR
Intervention: PROX1 protein in primary glioblastomas
Number of subjects: 340

Group type: COMPARATOR
Intervention: Gene expression data from the Cancer Genome Atlas
Number of subjects: 340
Study: 25024177

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP)
Number of subjects: 48
Study: 22867037

Group type: EXPERIMENTAL
Intervention: Low-dose alcohol (0.4 g/kg)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: High-dose alcohol (0.8 g/kg)
Number of subjects: 182
Study: 20883542

Group type: EXPERIMENTAL
Intervention: Efalizumab-based regimen (daclizumab induction, 6-month course of tacrolimus, maintenance with efalizumab and mycophenolate mofetil)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Edmonton protocol (standard regimen)
Number of subjects: 12
Study: 18512085

Group type: EXPERIMENTAL
Intervention: Cervical MRI at baseline and repeated after 3 months
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Clinical follow-ups after 3 and 12 months
Number of subjects: 178
Study: 15823211

Group type: EXPERIMENTAL
Intervention: Multifaceted behavioral intervention including training of opinion leaders and dissemination of evidence-based guidelines
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard in-service training activities
Number of subjects: 24
Study: 12618532

Group type: EXPERIMENTAL
Intervention: Interferon‐α-2b (INF‐α) and ribavirin therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 55
Study: 10375932

Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: LLETZ treatment
Number of subjects: 2046
Study: 8964729

Group type: EXPERIMENTAL
Intervention: Fenoterol (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1997835

Group type: EXPERIMENTAL
Intervention: Radiation plus fluorouracil (combined therapy)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Postoperative radiation alone (control)
Number of subjects: 204
Study: 6325355

Group type: EXPERIMENTAL
Intervention: 0.2 g NaHCO3/kg body weight
Number of subjects: 8

Group type: COMPARATOR
Intervention: NaCl
Number of subjects: 8
Study: 31442486

Group type: EXPERIMENTAL
Intervention: break-wall condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: auto-wall condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: no-wall condition
Number of subjects: 0
Study: 29431536

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (POMx)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: POMx + NAC (BOTH)
Number of subjects: 8
Study: 27247936

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (contralateral side without treatment)
Number of subjects: 20
Study: 24999148

Group type: EXPERIMENTAL
Intervention: Facilitated tucking during endotracheal suctioning
Number of subjects: 34

Group type: COMPARATOR
Intervention: No intervention (suctioning without facilitated tucking)
Number of subjects: 34
Study: 22212885

Group type: EXPERIMENTAL
Intervention: Complex course obstacle negotiation exercise (CC)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Simple course obstacle negotiation exercise (SC)
Number of subjects: 157
Study: 20416263

Group type: EXPERIMENTAL
Intervention: Zoster vaccine
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 17996821

Group type: EXPERIMENTAL
Intervention: bucindolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 16128369

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg) added to ACE inhibitor therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (ACE inhibitors only)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Comparison between losartan group and control group
Number of subjects: 33
Study: 12918884

Group type: EXPERIMENTAL
Intervention: 20 mg2/ml HA (sodium hyaluronate)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 408
Study: 10325520

Group type: EXPERIMENTAL
Intervention: finasteride (5 mg/day)
Number of subjects: 18882

Group type: COMPARATOR
Intervention: placebo (1 tablet/day)
Number of subjects: 18882
Study: 8963037

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily
Number of subjects: 111

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 111
Study: 1921527

Group type: EXPERIMENTAL
Intervention: New antiplatelet agent
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1200
Study: 7391515

Group type: EXPERIMENTAL
Intervention: Individual programming in visual and perceptual development at appropriate developmental levels.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Instruction in physical education, art or music classes (Control group).
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Individualized reading assistance (both groups).
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: The Informal Reading Inventory (Temple University), Word Reading and Paragraph Meaning subtests of the Stanford Achievement Tests.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: The Informal Word Recognition Inventory (Daniels) and the Spelling subtest of the Stanford Achievement Tests.
Number of subjects: 36
Study: 31724147

Group type: EXPERIMENTAL
Intervention: Dysphagia therapy (original treatment method)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 60
Study: 28528077

Group type: EXPERIMENTAL
Intervention: SLIMMER diabetes prevention intervention (10-month combined dietary and physical activity programme)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: SLIMMER diabetes prevention intervention
Number of subjects: 316
Study: 26170625

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg twice a day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study: 23940010

Group type: COMPARATOR
Intervention: Empagliflozin (1-100 mg q.d. for ≤12 weeks)
Number of subjects: 974
Study: 21900636

Group type: EXPERIMENTAL
Intervention: Minocycline 100 mg orally every 12 hours
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 19775465

Group type: EXPERIMENTAL
Intervention: Group follow-up at 6 and 12 months post DAFNE training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional one-to-one clinic visits (Control)
Number of subjects: 0
Study: 16979840

Group type: EXPERIMENTAL
Intervention: C‐ion RT with a total dose of 66 GyE in 20 fractions
Number of subjects: 172
Study: 15284212

Group type: EXPERIMENTAL
Intervention: Diane/cetrorelix protocol
Number of subjects: 49

Group type: COMPARATOR
Intervention: GnRH agonist long protocol
Number of subjects: 49
Study: 12663276

Group type: EXPERIMENTAL
Intervention: SFA-rich diet (38% fat, 20% SFA)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Change from SFA-rich diet to Cho-rich diet (30% fat, < 10% SFA, 55% carbohydrate)
Number of subjects: 97
Study: 9457935

Group type: COMPARATOR
Intervention: Diane 35 alone (n = 22)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Diane 35 plus spironolactone [100 mg] (n = 28)
Number of subjects: 50
Study: 8549581

Group type: EXPERIMENTAL
Intervention: Sodium citrate (C, 0.4 g.kg‐1 body mass)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (P, sodium chloride 0.045 g.kg‐1 body mass)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium citrate (C)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: N-P and N-C conditions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: HH conditions
Number of subjects: 8
Study: 2227277

Group type: EXPERIMENTAL
Intervention: Salsalate (3.0 g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (3.9 g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 492883

Group type: EXPERIMENTAL
Intervention: Experimental group tested for accuracy of recall while maintaining the images
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group tested for accuracy of recall after blinking their eyes and turning their heads to erase the images
Number of subjects: 12
Study: 31942729

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Epidural Analgesia combined with General Anesthesia (GII)
Number of subjects: 116
Study: 31664974

Group type: EXPERIMENTAL
Intervention: UPRIGHT intervention (whole school approach with 18 skills related to Mindfulness, Coping, Efficacy, and Social and Emotional Learning)
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Control group (17 schools)
Number of subjects: 6000
Study: 28506905

Group type: EXPERIMENTAL
Intervention: 8mm covered stent
Number of subjects: 127

Group type: COMPARATOR
Intervention: 10mm covered stent
Number of subjects: 127
Study: 26091594

Group type: EXPERIMENTAL
Intervention: ADHD Rating Scale-IV (ADHD RS-IV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adult ADHD Self-Report Scale (ASRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ADHD RS-IV and ASRS
Number of subjects: 0
Study: 23333018

Group type: EXPERIMENTAL
Intervention: CHARTWEL (continuous hyperfractionated accelerated radiotherapy)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 163
Study: 21388487

Group type: EXPERIMENTAL
Intervention: Subcuticular incision
Number of subjects: 20

Group type: COMPARATOR
Intervention: Collagen dermal filler
Number of subjects: 20
Study: 19699261

Group type: EXPERIMENTAL
Intervention: BT-11
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 17452147

Group type: EXPERIMENTAL
Intervention: Costar stent (Conor MedSystems)
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Taxus stent (Boston Scientific)
Number of subjects: 1700
Study: 14980191

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Albuterol 200 microg
Number of subjects: 36
Study: 11725826

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) 0.6 g, three times daily, for 12 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (hydrogel)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups (CLA and placebo)
Number of subjects: 20
Study: 9514413

Group type: COMPARATOR
Intervention: Step 1 diet
Number of subjects: 103

Group type: COMPARATOR
Intervention: Low-Sat diet
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Average American diet (AAD)
Number of subjects: 103
Study: 30940771

Group type: EXPERIMENTAL
Intervention: Ginseng (100 mg twice daily)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Ginseng
Number of subjects: 168
Study: 28931588

Group type: EXPERIMENTAL
Intervention: +HyD3 dairy drink
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: +D3 dairy drink
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (nonfortified dairy drink)
Number of subjects: 17
Study: 25926408

Group type: EXPERIMENTAL
Intervention: Coarse+LBG treatment (larger, 6-μm mean droplet size with 0.5% locust bean gum)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fine+LBG treatment (smaller, 0.4-μm mean droplet size with LBG)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Coarse treatment (larger, 6-μm mean droplet size)
Number of subjects: 11
Study: 24282895

Group type: EXPERIMENTAL
Intervention: Information leaflet on antibiotics with delayed prescription
Number of subjects: 115

Group type: COMPARATOR
Intervention: Delayed prescription (control group)
Number of subjects: 115
Study: 19480709

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (PR) for three years
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (standard care only)
Number of subjects: 80
Study: 17356139

Group type: EXPERIMENTAL
Intervention: Topical fibrin spray
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (no pharmacological intervention)
Number of subjects: 150
Study: 15239286

Group type: EXPERIMENTAL
Intervention: Total gastrectomy with preservation of hepatic vagus branches and lower esophageal sphincter (Group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Total gastrectomy with D2 lymphadenectomy and excision of lower esophageal sphincter (Group B)
Number of subjects: 50
Study: 12607480

Group type: EXPERIMENTAL
Intervention: Position‐changing phototherapy (changing from supine to prone position every 2 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional fixed‐position phototherapy
Number of subjects: 0
Study: 9819070

Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride (50-200 mg/d)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 9098302

Group type: EXPERIMENTAL
Intervention: 1% lissamine green
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1% rose bengal
Number of subjects: 20
Study: 2653622

Group type: EXPERIMENTAL
Intervention: Fenofibrate 100 mg three times a day with meals
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 147
Study: 661730

Group type: EXPERIMENTAL
Intervention: 100 mg benzbromarone (Normurat)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2.0 g probenecid
Number of subjects: 40
Study: 30739411

Group type: EXPERIMENTAL
Intervention: A‐PRF and Î²‐TCP composite in a 2:1 ratio (group B)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: A‐PRF and Î²‐TCP composite in a 4:1 ratio (group C)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: A‐PRF and Î²‐TCP composite in a 1:2 ratio (group D)
Number of subjects: 32

Group type: COMPARATOR
Intervention: A‐PRF and Î²‐TCP composite in a 1:1, 1:4, or 2:1 ratios (groups A, E, and B respectively)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Biomechanical tests for group B
Number of subjects: 32
Study: 28777646

Group type: EXPERIMENTAL
Intervention: Novel scheme for high-threshold fault-tolerant classical computation (FTCC) with a wiring structure that reduces circuit complexity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unitary implementation of FTCC
Number of subjects: 0
Study: 25464004

Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection of the prostate
Number of subjects: 137

Group type: COMPARATOR
Intervention: Monopolar transurethral resection of the prostate
Number of subjects: 137
Study: 22751032

Group type: EXPERIMENTAL
Intervention: Gabapentin-morphine combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study: 21332740

Group type: EXPERIMENTAL
Intervention: Non-invasive management of caries
Number of subjects: 920

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 920
Study: 19701833

Group type: EXPERIMENTAL
Intervention: Combination of levothyroxine and liothyronine for at least 4 months
Number of subjects: 71

Group type: COMPARATOR
Intervention: Levothyroxine monotherapy
Number of subjects: 71
Study: 17087127

Group type: EXPERIMENTAL
Intervention: Cannabinoids
Number of subjects: 0
Study: 14757590

Group type: EXPERIMENTAL
Intervention: Early Detection (ED) program
Number of subjects: 281

Group type: COMPARATOR
Intervention: No Early Detection (No-ED) program
Number of subjects: 281
Study: 11123591

Group type: EXPERIMENTAL
Intervention: Expert tutor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-expert tutor
Number of subjects: 0
Study: 9543119

Group type: EXPERIMENTAL
Intervention: Growth hormone treatment at a mean dosage of 0.4 +/- 0.1 U/kg x week for an average of 4.6 +/- 2.5 years
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (untreated short children born with IUGR)
Number of subjects: 70
Study: 8067759

Group type: EXPERIMENTAL
Intervention: Cefixime (400 mg once daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ofloxacin (200 mg twice a day)
Number of subjects: 100
Study: 3143313

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0
Study: 30870291

Group type: EXPERIMENTAL
Intervention: Intravenous furosemide 10 mg
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 144
Study: 28169215

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) angioplasty
Number of subjects: 367
Study: 26093871

Group type: EXPERIMENTAL
Intervention: Continue ACEI/ARB
Number of subjects: 208

Group type: COMPARATOR
Intervention: Hold ACEI/ARB
Number of subjects: 208
Study: 23556505

Group type: EXPERIMENTAL
Intervention: Self-regulation with Small Changes (100 calorie changes and 2000 additional steps per day)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Self-regulation with Large Changes (create a weight loss buffer of 5-10 pounds once per year)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Minimal intervention control
Number of subjects: 600
Study: 21309063

Group type: EXPERIMENTAL
Intervention: Oral hypoglycaemic agents (pioglitazone, metformin, glipizide)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Insulin therapy
Number of subjects: 21
Study: 19478041

Group type: COMPARATOR
Intervention: Rituximab alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Rituximab + cyclophosphamide
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 17761585

Group type: EXPERIMENTAL
Intervention: Foreign-born women living in the US for 4 or fewer years
Number of subjects: 662

Group type: COMPARATOR
Intervention: Native-born women
Number of subjects: 662

Group type: COMPARATOR
Intervention: White women
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: Women speaking both English and Spanish at home
Number of subjects: 662